Journal article 552 views 90 downloads
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes
Scientific Reports, Volume: 11, Issue: 1
Swansea University Authors: Jim Rafferty , David Owens
-
PDF | Version of Record
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License
Download (1.75MB)
DOI (Published version): 10.1038/s41598-021-93096-w
Abstract
Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CK...
Published in: | Scientific Reports |
---|---|
ISSN: | 2045-2322 |
Published: |
Springer Science and Business Media LLC
2021
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa58154 |
first_indexed |
2021-10-25T15:15:39Z |
---|---|
last_indexed |
2021-10-26T03:24:22Z |
id |
cronfa58154 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-10-25T16:17:20.5743854</datestamp><bib-version>v2</bib-version><id>58154</id><entry>2021-09-30</entry><title>Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes</title><swanseaauthors><author><sid>52effe759a718bd36eb12cdd10fe1a09</sid><ORCID>0000-0002-1667-7265</ORCID><firstname>Jim</firstname><surname>Rafferty</surname><name>Jim Rafferty</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-09-30</date><deptcode>MEDS</deptcode><abstract>Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m2. The observational study cohort used for model development consisted of data from a primary care dataset of 20,510 multi-ethnic individuals with T2DM from London, UK (2007–2018). Discrimination and calibration of the resulting prediction models developed using cox regression were assessed using the c-statistic and calibration slope, respectively. Models were internally validated using tenfold cross-validation and externally validated on 13,346 primary care individuals from Wales, UK. The simplest model was simplified into a risk score to enable implementation in community-based medicine. The derived full model included demographic, laboratory parameters, medication-use, cardiovascular disease history (CVD) and sight threatening retinopathy status (STDR). Two less resource-intense models were developed by excluding CVD and STDR in the second model and HbA1c and HDL in the third model. All three 5-year risk models had good internal discrimination and calibration (optimism adjusted C-statistics were each 0.85 and calibration slopes 0.999–1.002). In Wales, models achieved excellent discrimination(c-statistics ranged 0.82–0.83). Calibration slopes at 5-years suggested models over-predicted risks, however were successfully updated to accommodate reduced incidence of stage 3 CKD in Wales, which improved their alignment with the observed rates in Wales (E/O ratios near to 1). The risk score demonstrated similar model performance compared to direct evaluation of the cox model. These resource-driven risk prediction models may enable universal screening for Stage 3 CKD to enable targeted early optimisation of risk factors for CKD.</abstract><type>Journal Article</type><journal>Scientific Reports</journal><volume>11</volume><journalNumber>1</journalNumber><paginationStart/><paginationEnd/><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2045-2322</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-07-01</publishedDate><doi>10.1038/s41598-021-93096-w</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>Global Challenges Research Fund and UK Research and Innovation through the Medical Research Council grant number MR/P027881/1</funders><lastEdited>2021-10-25T16:17:20.5743854</lastEdited><Created>2021-09-30T11:21:31.6414495</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Sarega</firstname><surname>Gurudas</surname><order>1</order></author><author><firstname>Manjula</firstname><surname>Nugawela</surname><order>2</order></author><author><firstname>A. Toby</firstname><surname>Prevost</surname><order>3</order></author><author><firstname>Thirunavukkarasu</firstname><surname>Sathish</surname><order>4</order></author><author><firstname>Rohini</firstname><surname>Mathur</surname><order>5</order></author><author><firstname>Jim</firstname><surname>Rafferty</surname><orcid>0000-0002-1667-7265</orcid><order>6</order></author><author><firstname>Kevin</firstname><surname>Blighe</surname><order>7</order></author><author><firstname>Ramachandran</firstname><surname>Rajalakshmi</surname><order>8</order></author><author><firstname>Anjana R.</firstname><surname>Mohan</surname><order>9</order></author><author><firstname>Jebarani</firstname><surname>Saravanan</surname><order>10</order></author><author><firstname>Azeem</firstname><surname>Majeed</surname><order>11</order></author><author><firstname>Viswanthan</firstname><surname>Mohan</surname><order>12</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>13</order></author><author><firstname>John</firstname><surname>Robson</surname><order>14</order></author><author><firstname>Sobha</firstname><surname>Sivaprasad</surname><order>15</order></author><author><firstname>(the ORNATE India Study</firstname><surname>Group)</surname><order>16</order></author></authors><documents><document><filename>58154__21296__8b82638c2f8e4cb5b01c85de835d5eca.pdf</filename><originalFilename>58154.pdf</originalFilename><uploaded>2021-10-25T16:16:02.3182584</uploaded><type>Output</type><contentLength>1839125</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2021-10-25T16:17:20.5743854 v2 58154 2021-09-30 Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes 52effe759a718bd36eb12cdd10fe1a09 0000-0002-1667-7265 Jim Rafferty Jim Rafferty true false 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2021-09-30 MEDS Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m2. The observational study cohort used for model development consisted of data from a primary care dataset of 20,510 multi-ethnic individuals with T2DM from London, UK (2007–2018). Discrimination and calibration of the resulting prediction models developed using cox regression were assessed using the c-statistic and calibration slope, respectively. Models were internally validated using tenfold cross-validation and externally validated on 13,346 primary care individuals from Wales, UK. The simplest model was simplified into a risk score to enable implementation in community-based medicine. The derived full model included demographic, laboratory parameters, medication-use, cardiovascular disease history (CVD) and sight threatening retinopathy status (STDR). Two less resource-intense models were developed by excluding CVD and STDR in the second model and HbA1c and HDL in the third model. All three 5-year risk models had good internal discrimination and calibration (optimism adjusted C-statistics were each 0.85 and calibration slopes 0.999–1.002). In Wales, models achieved excellent discrimination(c-statistics ranged 0.82–0.83). Calibration slopes at 5-years suggested models over-predicted risks, however were successfully updated to accommodate reduced incidence of stage 3 CKD in Wales, which improved their alignment with the observed rates in Wales (E/O ratios near to 1). The risk score demonstrated similar model performance compared to direct evaluation of the cox model. These resource-driven risk prediction models may enable universal screening for Stage 3 CKD to enable targeted early optimisation of risk factors for CKD. Journal Article Scientific Reports 11 1 Springer Science and Business Media LLC 2045-2322 1 7 2021 2021-07-01 10.1038/s41598-021-93096-w COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Global Challenges Research Fund and UK Research and Innovation through the Medical Research Council grant number MR/P027881/1 2021-10-25T16:17:20.5743854 2021-09-30T11:21:31.6414495 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Sarega Gurudas 1 Manjula Nugawela 2 A. Toby Prevost 3 Thirunavukkarasu Sathish 4 Rohini Mathur 5 Jim Rafferty 0000-0002-1667-7265 6 Kevin Blighe 7 Ramachandran Rajalakshmi 8 Anjana R. Mohan 9 Jebarani Saravanan 10 Azeem Majeed 11 Viswanthan Mohan 12 David Owens 0000-0003-1002-1238 13 John Robson 14 Sobha Sivaprasad 15 (the ORNATE India Study Group) 16 58154__21296__8b82638c2f8e4cb5b01c85de835d5eca.pdf 58154.pdf 2021-10-25T16:16:02.3182584 Output 1839125 application/pdf Version of Record true © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License true eng http://creativecommons.org/licenses/by/4.0/ |
title |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
spellingShingle |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes Jim Rafferty David Owens |
title_short |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_full |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_fullStr |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_full_unstemmed |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_sort |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
author_id_str_mv |
52effe759a718bd36eb12cdd10fe1a09 2fd4b7c3f82c6d3bd546eff61ff944e9 |
author_id_fullname_str_mv |
52effe759a718bd36eb12cdd10fe1a09_***_Jim Rafferty 2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens |
author |
Jim Rafferty David Owens |
author2 |
Sarega Gurudas Manjula Nugawela A. Toby Prevost Thirunavukkarasu Sathish Rohini Mathur Jim Rafferty Kevin Blighe Ramachandran Rajalakshmi Anjana R. Mohan Jebarani Saravanan Azeem Majeed Viswanthan Mohan David Owens John Robson Sobha Sivaprasad (the ORNATE India Study Group) |
format |
Journal article |
container_title |
Scientific Reports |
container_volume |
11 |
container_issue |
1 |
publishDate |
2021 |
institution |
Swansea University |
issn |
2045-2322 |
doi_str_mv |
10.1038/s41598-021-93096-w |
publisher |
Springer Science and Business Media LLC |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m2. The observational study cohort used for model development consisted of data from a primary care dataset of 20,510 multi-ethnic individuals with T2DM from London, UK (2007–2018). Discrimination and calibration of the resulting prediction models developed using cox regression were assessed using the c-statistic and calibration slope, respectively. Models were internally validated using tenfold cross-validation and externally validated on 13,346 primary care individuals from Wales, UK. The simplest model was simplified into a risk score to enable implementation in community-based medicine. The derived full model included demographic, laboratory parameters, medication-use, cardiovascular disease history (CVD) and sight threatening retinopathy status (STDR). Two less resource-intense models were developed by excluding CVD and STDR in the second model and HbA1c and HDL in the third model. All three 5-year risk models had good internal discrimination and calibration (optimism adjusted C-statistics were each 0.85 and calibration slopes 0.999–1.002). In Wales, models achieved excellent discrimination(c-statistics ranged 0.82–0.83). Calibration slopes at 5-years suggested models over-predicted risks, however were successfully updated to accommodate reduced incidence of stage 3 CKD in Wales, which improved their alignment with the observed rates in Wales (E/O ratios near to 1). The risk score demonstrated similar model performance compared to direct evaluation of the cox model. These resource-driven risk prediction models may enable universal screening for Stage 3 CKD to enable targeted early optimisation of risk factors for CKD. |
published_date |
2021-07-01T05:25:39Z |
_version_ |
1821472498630262784 |
score |
11.0583515 |